ARYA SCIENCES ACQUISITION CORP.

ARYA Sciences Acquisition Corp., trading under the ticker ARYA, is a life sciences-focused special purpose acquisition company sponsored by Perceptive Advisors, a healthcare-dedicated investment firm. The vehicle completed its initial public offering in 2019 targeting opportunities in the biopharmaceutical and life sciences sectors. In June 2020, the company filed a DEFM14A — a definitive proxy statement — with the SEC, signaling an active business combination requiring shareholder approval and marking a key milestone in its de-SPAC process. The filing, bearing accession number 0001193125-20-165771, reflects the company's progression from blank-check vehicle to executing a target transaction. Sign up for a free SpacDesk account to access the full filing history, deal timeline, and sponsor analytics for ARYA and hundreds of other SPAC vehicles.